Entrada Therapeutics
TRDA
#7125
Rank
HK$3.18 B
Marketcap
HK$84.80
Share price
0.83%
Change (1 day)
-14.71%
Change (1 year)

Entrada Therapeutics (TRDA) - P/B ratio

P/B ratio as of March 2025 : 0.9568

According to Entrada Therapeutics's latest financial reports the company has a price-to-book ratio of 1.90565.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Entrada Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.54-25.77%
2023-12-312.084%
2022-12-312.0011.67%
2021-12-311.79
2020-12-31N/A